Why the Jan Aushadhi Scheme Has Lost Its Steam in India?
- 1*,
- 2,
- 3
- 1People’s College of Medical Sciences and Research Centre, People’s University, Bhopal, Madhya Pradesh, India.
- 2Centre for Scientific Research and Development, People’s University, Bhopal, Madhya Pradesh, India.
- 3Dean, School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Vijay Thawani
People’s College of Medical Sciences and Research Centre, People’s University, Bhopal, Madhya Pradesh, India.
Email: vijaythawani@rediffmail.com
Copyright: © 2017 The Author(s). This is an open access article.
Published: Jan 1, 2017, Received: Mar 11, 2017, Accepted: Jul 10, 2017
Abstract
The Jan Aushadhi Scheme (JAS) initiated by the Government of India is a powerful intervention against the unjustifiable pricing of medicines by private pharmaceutical industry, to make the generic medicines available at affordable prices. The marginalized populations of India are not able to afford many branded medicines; hence, there is an urgent need for making the cheaper generics available to Indians in the best interest of populations. It has been observed that lack of awareness in the public, distribution of free medicines by state governments, lack of support for JAS, poor supply chain, and doctors not prescribing generic medicines are the major constraints faced by the JAS leading to its poor success.
Keywords
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026